-
Product Insights
Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2026" provides an overview of Plaque Psoriasis (Psoriasis Vulgaris) Clinical trials scenario. This report provides top line data relating to the clinical trials on Plaque Psoriasis (Psoriasis Vulgaris). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Uveitis - Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Uveitis - Global Clinical Trials Review, 2026" provides an overview of Uveitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Uveitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Huntington Disease - Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Huntington Disease - Global Clinical Trials Review, 2026" provides an overview of Huntington Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Huntington Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Malaria - Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Malaria - Global Clinical Trials Review, 2026" provides an overview of Malaria Clinical trials scenario. This report provides top line data relating to the clinical trials on Malaria. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Post-Traumatic Stress Disorder (PTSD) - Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Post-Traumatic Stress Disorder (PTSD) - Global Clinical Trials Review, 2026" provides an overview of Post-Traumatic Stress Disorder (PTSD) Clinical trials scenario. This report provides top line data relating to the clinical trials on Post-Traumatic Stress Disorder (PTSD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Rheumatoid Arthritis - Global Clinical Trials Review, 2026
Understand the Global Clinical Trials Landscape for Rheumatoid Arthritis Rheumatoid arthritis remains a key focus area in global clinical research, with ongoing trials shaping the future of treatment and innovation. This report provides a comprehensive snapshot of the global clinical trials landscape, covering trial activity across regions, countries (G7 & E7), phases, statuses, endpoints, and sponsor types. As a result, you gain a clear understanding of where research is accelerating and how the competitive landscape is evolving. Report Value Proposition...
-
Product Insights
Hyperuricemia - Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Hyperuricemia - Global Clinical Trials Review, 2026" provides an overview of Hyperuricemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperuricemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Pulmonary Arterial Hypertension - Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Pulmonary Arterial Hypertension - Global Clinical Trials Review, 2026" provides an overview of Pulmonary Arterial Hypertension Clinical trials scenario. This report provides top line data relating to the clinical trials on Pulmonary Arterial Hypertension. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Parkinson's Disease - Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Parkinson's Disease - Global Clinical Trials Review, 2026" provides an overview of Parkinson's Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Parkinson's Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
EU Pharma Reset Enters Make-or-Break Phase
In the EU, 2025–26 has been an exceptionally busy time for pharmaceutical-related reforms. Political agreement on the pharma reform package in late 2025, coupled with progress on finalizing the Critical Medicines Act (CMA) and the Biotech Act in early 2026, mean that many of the uncertainties over policy direction have now been resolved. As such, the EU is starting to move into a make-or-break period of reform implementation.
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.